DE2065956B2 - p-Acyloxime-phenoxyacetic acids and derivatives, methods for their adjustment and pharmaceutical agents - Google Patents
p-Acyloxime-phenoxyacetic acids and derivatives, methods for their adjustment and pharmaceutical agentsInfo
- Publication number
- DE2065956B2 DE2065956B2 DE19702065956 DE2065956A DE2065956B2 DE 2065956 B2 DE2065956 B2 DE 2065956B2 DE 19702065956 DE19702065956 DE 19702065956 DE 2065956 A DE2065956 A DE 2065956A DE 2065956 B2 DE2065956 B2 DE 2065956B2
- Authority
- DE
- Germany
- Prior art keywords
- acid
- water
- alcohol
- acyloxime
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C8/00—Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C8/06—Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases
- C23C8/08—Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases only one element being applied
- C23C8/10—Oxidising
- C23C8/12—Oxidising using elemental oxygen or ozone
- C23C8/14—Oxidising of ferrous surfaces
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C8/00—Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C8/80—After-treatment
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
in der bedeuten:in which:
R' OH, NHOH, Morpholine), Piperidino oder Hexamethylenimine.R 'OH, NHOH, morpholine), piperidino or hexamethyleneimines.
2. μ-Acetyloxim-phenoxyessigsäure-morpholinamid der Formel2. µ-Acetyloxime-phenoxyacetic acid-morpholine amide the formula
H3C-CH 3 CC
NOHNOH
O—CH2-C-NO-CH 2 -CN
OHOH
R —C—< O V-O-CH2-C-OHR —C— <O VO-CH 2 -C-OH
O OO O
umgesetzt wird, die anschließend, gegebenenfalls nach Überführung der Carboxylgruppe in die entsprechende Carbonsäureamidgruppe über einen entsprechenden Ester oder das Säurechlorid, mit Hydroxylamin-hydrochlorid am Rückfluß in Has Oxim übergeführt wird.is implemented, which then, optionally after conversion of the carboxyl group into the corresponding carboxamide group via a corresponding ester or the acid chloride, with Hydroxylamine hydrochloride is converted into Has oxime under reflux.
4. Pharmazeutische Mittel, dadurch gekennzeichnet, daß sie die Verbindungen nach Anspruch 1 als Wirkstoff neben üblichen Hilfs- und Trägerstoffen enthalten.4. Pharmaceutical agents, characterized in that they contain the compounds according to claim 1 as Contains active ingredient in addition to the usual auxiliaries and carriers.
Die Erfindung betrifft den Gegenstand der Ansprüche. The invention relates to the subject matter of the claims.
Im folgenden wird die Herstellung von Zwischenverbindungen erläutert, über die die erfindungsgemäßen Verbindungen hergestellt werden können.The following explains the preparation of intermediate compounds via which the inventive Connections can be made.
Die entsprechende p-Acylphenoxyessigsäure kann nach üblichen Veresterungsverfahren in schwefelsaurem Medium mit einem Alkohol in den entsprechenden Ester übergeführt werden.The corresponding p-acylphenoxyacetic acid can be converted into sulfuric acid by conventional esterification processes Medium can be converted into the corresponding ester with an alcohol.
ISIS
3. Verfahren zur Herstellung der Verbindungen nach Anspruch 1 und 2, dadurch gekennzeichnet, daß in an sich bekannter Weise Chloressigsäure mit einem p- Acylphenol der allgemeinen Formel3. A method for the preparation of the compounds according to claim 1 and 2, characterized in that in a manner known per se, chloroacetic acid with a p-acylphenol of the general formula
JOJO
mit R wie in Anspruch 1with R as in claim 1
durch Kochen am Rückfluß in Gegenwart von Natriumhydroxid zur entsprechenden p-Acyl-phenoxyessigsäure der allgemeinen Formelby refluxing in the presence of sodium hydroxide to give the corresponding p-acyl-phenoxyacetic acid the general formula
4040
4545
5050
6060
t>5t> 5
das entsprechende Amid übergeführt werden.the corresponding amide can be converted.
Das Amid kann ferner auch aus der entsprechenden Säure über die nach an sich bekannten Verfahren hergestellte Zwischenstufe des Säurechlorids hergestellt werden.The amide can also be obtained from the corresponding acid by methods known per se prepared intermediate of the acid chloride are prepared.
Die Ester oder Oxime können ihrerseits durch Kochen am Rückfluß in Äthanol mit Hydroxylamin und Soda in die entsprechende Phenoxymethylcarbohydroxamsaure überführt werden.The esters or oximes can in turn by refluxing in ethanol with hydroxylamine and Soda can be converted into the corresponding phenoxymethylcarbohydroxamic acid.
Die erfindungsgemäßen Verbindungen, die über die vorstehend erwähnten Zwischenprodukte herstellbar sind, zeichnen sich besonders durch ihre pharmakologische Wirksamkeit aus, aufgrund deren sie z.B. als Wirkstoffe in Mitteln gegen Husten geeignet sind.The compounds according to the invention which can be prepared via the above-mentioned intermediates are, are particularly characterized by their pharmacological effectiveness, due to which they are e.g. Active ingredients in agents against cough are suitable.
Die erfindungsgemäßen Verbindungen und ihre Herstellung werden nachstehend anhand von Ausführungsbeispielen näher erläutertThe compounds according to the invention and their preparation are illustrated below with the aid of working examples explained in more detail
Herstellung von p-Acyloximphenoxyessigsäuren
und ihren DerivatenProduction of p-acyloximphenoxyacetic acids
and their derivatives
1. Herstellung von p-Acylphenoxyessigsäuren1. Production of p-acylphenoxyacetic acids
0,6 mol Natriumhydroxid, 0,3 mol p-Hydroxybenzaldehyd oder p-Hydroxyacetophenon sowie 03 mol Chloressigsäure werden in einem Gefäß mit 600 ml Wasser vorgelegt0.6 mole sodium hydroxide, 0.3 mole p-hydroxybenzaldehyde or p-hydroxyacetophenone and 03 mol Chloracetic acid are placed in a vessel with 600 ml of water
Die Lösung wird 8 Stunden am Rückfluß zum Sieden erhitzt Nach Abkühlung wird mit 12n-Salzsäure auf pH 3 angesäuert Die ausgefallene Säure wird abfiltriert in Äther wieder gelöst und mit verdünnter Säure extrahiert Die Säure wird aus Wasser durch Abkühlen auf Umgebungstemperatur umkristallisiertThe solution is refluxed for 8 hours. After cooling, it is made up with 12N hydrochloric acid pH 3 acidified. The precipitated acid is filtered off and redissolved in ether and diluted with dilute acid The acid is recrystallized from water by cooling to ambient temperature
Die mittlere Ausbeute dieser Verfahrensweise liegt bei etwa 65%.The average yield of this procedure is about 65%.
Diese Verfahrensweise gestattet die Herstellung von p-Formyl-phenoxyessigsäure und p-Acetyl-phenoxyessigsäure. This procedure allows the production of p-formyl-phenoxyacetic acid and p-acetyl-phenoxyacetic acid.
2. Veresterung2. Esterification
10 g einer nach 1. erhaltenen Säure werden in 150 ml Methanol oder Äthanol gelöst. Hierzu werden 150 ml wasserfreies Benzol und 1 ml 36 n-Schwefelsäure zugesetzt Nach 2 Stunden Kochen am Rückfluß wird das azeotrope Benzol-Alkohol-Gemisch abdestilliert, bis das ganze Benzol entfernt ist10 g of an acid obtained according to 1. are in 150 ml Dissolved methanol or ethanol. For this purpose 150 ml of anhydrous benzene and 1 ml of 36 N sulfuric acid are added added After 2 hours of refluxing, the azeotropic benzene-alcohol mixture is distilled off, until all of the benzene is removed
Die alkoholische Lösung wird dann im Vakuum eingeengt Das abgeschiedene öl wird in 200 ml Äthyläther aufgenommen, worauf die Ätherlösung mit Wasser gewaschen und dann über Natriumsulfat getrocknet wird. Nach Eindampfen der Ätherlösung im Vakuum wird der Ester je nach dem Derivat in Form eines gelben ö,s oder kristallin erhalten.The alcoholic solution is then concentrated in vacuo. The separated oil is dissolved in 200 ml Ethyl ether added, whereupon the ethereal solution was washed with water and then over sodium sulfate is dried. After evaporation of the ethereal solution in vacuo, the ester becomes in shape depending on the derivative of a yellow ö, s or crystalline obtained.
3. Herstellung der Amide
3.1 aus den Estern3. Preparation of the amides
3.1 from the esters
8 g eines nach 2. erhaltenen Esters werden in etwa 25 ml eines vorher über Kaliumcarbonat getrockneten Amins gelöst Diese Lösung wird 3 Stunden am Rückfluß zum Sieden erhitzt. Das entsprechende Amid kristallisiert im allgemeinen durch einfaches Abkühlen oder nach Zusatz einer geringen Menge Wasser aus. Die vollständige Ausfällung geschieht durch langsamen Zusatz von 200 bis 300 ml Wasser. Die Reinigung erfolgt durch Umkristallisieren in einer Mischung aus Alkohol8 g of an ester obtained according to 2. are dried in about 25 ml of one beforehand over potassium carbonate Amine dissolved. This solution is refluxed for 3 hours. The corresponding amide generally crystallizes out by simple cooling or after adding a small amount of water. the Complete precipitation occurs by slowly adding 200 to 300 ml of water. The cleaning takes place by recrystallization from a mixture of alcohol
32 aus den Säurechloriden 32 from the acid chlorides
Es ist ferner möglich, zunächst in üblicher Weise die Chloride der entsprechenden Säuren herzustellen, die dann unter denselben Bedingungen wie in 3.1 in Gegenwart eines Amins zum entsprechenden Amid umgesetzt werden.It is also possible first of all in the usual way To produce chlorides of the corresponding acids, the then under the same conditions as in 3.1 in the presence of an amine to give the corresponding amide implemented.
Hierzu kann beispielsweise wie folgt verfahren werden:This can be done, for example, as follows:
a) Das Morpholinamid der p-Formyl-phenoxyessigsäure (l-{p-Fonnyl-phenoxyacetyl)-morpholin) wird erhalten durch die vorstehend unter 3.1 oder 3.2 erwähnte Verfahrensweise. Die Ausbeute beträgt 65%. Das Amid ist in Alkohol löslich und in Wasser unlöslich. F. 116° Ca) The morpholine amide of p-formyl-phenoxyacetic acid (l- {p-Formyl-phenoxyacetyl) -morpholine) is obtained by the procedure mentioned under 3.1 or 3.2 above. The yield is 65%. The amide is soluble in alcohol and insoluble in water. 116 ° C
b) Das Morpholinamid der p-Acetyl-phenoxyessigsäure (!-(p-Acetyl-phenoxyacetylJ-morpholin) wird nach 3.1 erhalten; es ist löslich in Alkohol und unlöslich in Wasser und Petroläther. Ausbeute «Wfc;F.112°Cb) The morpholine amide of p-acetyl-phenoxyacetic acid (! - (p-acetyl-phenoxyacetylJ-morpholine) is obtained after 3.1; it is soluble in alcohol and insoluble in water and petroleum ether. yield «Wfc; F. 112 ° C
c) Das !-{p-Acetyl-phenoxyacetylJ-hexamethylenimin wird nach 3.1 in einer Ausbeute von 50% erhalten. Es ist löslich in Alkohol und Äther und unlöslich in Wasser; F. 78°Cc) The! - {p-Acetyl-phenoxyacetylI-hexamethyleneimine is obtained according to 3.1 in a yield of 50%. It is soluble in alcohol and ether and insoluble in Water; 78 ° C
d) Das Piperidinamid der p-Formyl-phenoxyessigsäure wird durch die Verfahrensweise gemäß 3.1 oder 32 erhalten. Man erhält ein kristallines Produkt, das in Äther, Alkohol und in den meisten organischen Lösungsmitteln löslich und in Petroläther und Wasser unlöslich ist Die Ausbeute beträgt etwa 60%;F.96°C.d) The piperidinamide of p-formyl-phenoxyacetic acid is obtained by the procedure according to 3.1 or 32. A crystalline product is obtained which soluble in ether, alcohol and in most organic solvents and in petroleum ether and Water is insoluble. The yield is about 60%; m.p. 96 ° C.
e) Das Piperidinamid der p-Acetyl-phenoxyessigsäure wird nach 3.1 als kristallines Produkt erhalten; die Ausbeute beträgt etwa 60%. Das Produkt ist in Alkohol und den meisten organischen Lösungsmitteln löslich und in Wasser, Äther und Petroläther unlöslich. F. 97°Ce) The piperidinamide of p-acetyl-phenoxyacetic acid is obtained as a crystalline product according to 3.1; the Yield is about 60%. The product is in alcohol and most organic solvents soluble and insoluble in water, ether and petroleum ether. 97 ° C
4. Herstellung der Oxime4. Manufacture of the oximes
0,1 mol eines nach 3. hergestellten Amids wird in ml absolutem Äthanol gelöst Hierzu werden 7 g Hydroxylamin-hydrochlorid und 4,8 g Soda hinzugefügt, worauf diese Mischung 3 Stunden am Rückfluß zum Sieden erhitzt wird.0.1 mol of an amide prepared according to 3. is in ml of absolute ethanol dissolved 7 g of hydroxylamine hydrochloride and 4.8 g of soda are added, whereupon this mixture is refluxed for 3 hours.
Vakuum kristallisiert das Oxim in der Wasser-Alkohoi-Lösung aus. Nach Filtration wird das Oxim durch Umkristallisieren in einer Alkohol-Wasser-Mischung gereinigtThe oxime crystallizes in a vacuum in the water-alcohol solution the end. After filtration, the oxime is recrystallized from an alcohol-water mixture cleaned
a) Das p-Formyloxim-phenoxyessigsäure-piperidinamid wird unter den vorstehenden Bedingungena) The p-formyloxime-phenoxyacetic acid-piperidinamide will be subject to the above conditions
ίο erhalten. Das kristallisierte Oxim fällt in einer Ausbeute von etwa 70% an; F. 135°C Es ist löslich in Alkohol und unlöslich in Wasser.ίο received. The crystallized oxime falls in a Yield of about 70%; F. 135 ° C. It is soluble in alcohol and insoluble in water.
b) Das p-Formyloxim-phenoxyessigsäure-morpholinamid wird unter den gleichen Bedingungenb) The p-formyloxime-phenoxyacetic acid-morpholine amide will be under the same conditions
is erhalten. Es ist löslich in Alkohol und unlöslich in Wasser; F. 169°C Die Ausbeute beträgt 60%.is received. It is soluble in and insoluble in alcohol Water; M.p. 169 ° C. The yield is 60%.
c) Die p-Acetyloxim-phenoxyessigsäure wird ebenfalls unter den vorstehend genannten Bedingungen bei einem nahezu alkalischen pH-Wert, wie er beimc) The p-acetyloxime-phenoxyacetic acid is also under the above-mentioned conditions at an almost alkaline pH value, as in
Menge an Hydroxylamin-hydrochlorid erhalten. Das Produkt fällt mit einer Ausbeute von 55% an; F. 1/7° C Es ist löslich in Alkohol und wäßriger Bicarbonatlösung und unlöslich in Wasser.Amount of hydroxylamine hydrochloride obtained. The product is obtained with a yield of 55%; F. 1/7 ° C It is soluble in alcohol and aqueous bicarbonate solution and insoluble in water.
d) Das p-Acetyloxim-phenoxyessigsäure-piperidinamid wird durch Kondensation des entsprechenden Amids mit Hydroxylamin-hydrochlorid in Alkohol in Gegenwart von Soda durch Kochen am Rückfluß und anschließende Reinigung erhalten. Die Aus-d) The p-acetyloxime-phenoxyacetic acid-piperidinamide is made by condensation of the corresponding amide with hydroxylamine hydrochloride in alcohol obtained in the presence of soda by refluxing and subsequent purification. From-
:io beute beträgt 70%. Das Produkt ist in Alkohol löslich und in Wasserunlöslich; F. 168°C.: io booty is 70%. The product is in alcohol soluble and insoluble in water; M.p. 168 ° C.
e) Das p-Acetyloxim-phenoxyessigsäure-morpholinamid wird nach der gleichen Verfahrensweise in einer Ausbeute von 70% erhalten. Das Produkt iste) The p-acetyloxime-phenoxyacetic acid-morpholine amide is obtained by the same procedure in a yield of 70%. The product is
r> löslich in Alkohol und unlöslich in Wasser. F. 145° C.r> soluble in alcohol and insoluble in water. F. 145 ° C.
f) Das p-Acetyloxim-phenoxyessigsäure-hexamethylenimid wird in einer Ausbeute von 60% erhalten. Es ist löslich in Alkohol und unlöslich in Wasser. F. 134° C.f) The p-acetyloxime-phenoxyacetic acid-hexamethyleneimide is obtained in a yield of 60%. It is soluble in alcohol and insoluble in water. 134 ° C.
Die erfindungsgemäßen Oxime zeichnen sich durch günstige pharmakologische Wirkung gegen Husten aus.The oximes according to the invention are distinguished by a favorable pharmacological action against coughing.
Die Wirksamkeit gegen Husten sowie die akute Toxizität wurden an Mäusen untersucht Als Vergleichssubstanz diente Codein. Die erhaltenen Ergebnisse sind in der Tabelle angegeben.The effectiveness against cough and the acute toxicity were investigated in mice. Codeine was used as the comparison substance. The results obtained are indicated in the table.
R —CR —C
NOHNOH
O —CH2-C-R'O —CH 2 -C-R '
IlIl
Verringerung
der Hustenzahl
() = Dosisreduction
the number of coughs
() = Dose
(mg/kg per os) (mg/kg)(mg / kg per os) (mg / kg)
Akute Toxizität
LDacute toxicity
LD
(mg/kg per os)(mg / kg per os)
CH3 CH 3
CH3 CH 3
3030th
4242
-50% (30)-50% (30)
-56% (75)-56% (75)
LD,„ = 750LD, "= 750
LD50 = 700LD 50 = 700
Rlink
R.
ID
(mg/kg per os)acute toxicity
ID
(mg / kg per os)
ED511 prozentuale
Verringerung
der Hustenzahl
() = Dosis
(mg/kg per os) (mg/kg)Efficacy against cough
ED 511 percentage
reduction
the number of coughs
() = Dose
(mg / kg per os) (mg / kg)
Codeincomparison
Codeine
Aus den Ergebnissen geht die günstige Wirkung bei therapeutischen Index gegenüber Codein als besonders
Husten bei gleicher ED50 wie für Codein sowie die günstig:
demgegenüber signifikant verringerte Toxizität der 25
erfindungsgemäßen Verbindungen hervor. p-Acetyloxim-phenoxyessigsäure- _,„The results show the beneficial effect at therapeutic index compared to codeine as a particularly cough at the same ED50 as for codeine as well as the favorable:
in contrast, significantly reduced toxicity of the 25th
compounds according to the invention. p-Acetyloxim-phenoxyessigsäure- _, "
p-Acetyloxim-phenoxyessigsäure-morpholinamid morpholinamid: = 25,0p-Acetyloxime-phenoxyacetic acid-morpholinamide morpholinamide: = 25.0
= CH3 R' = N= CH 3 R '= N
erweist sich dabei aufgrund seines vorteilhaftenproves to be advantageous because of its
Codein:Codeine:
220 30 220 30
7.37.3
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702065956 DE2065956C3 (en) | 1969-01-31 | 1970-01-27 | p-Acyloxime-phenoxyacetic acids and derivatives, processes for their preparation and pharmaceutical agents |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH151769A CH515873A (en) | 1969-01-31 | 1969-01-31 | Phenoxyacetic acid derivs |
| CH1302269A CH543472A (en) | 1969-01-31 | 1969-08-28 | Process for the preparation of phenoxyalkylcarboxylic acids |
| DE19702065956 DE2065956C3 (en) | 1969-01-31 | 1970-01-27 | p-Acyloxime-phenoxyacetic acids and derivatives, processes for their preparation and pharmaceutical agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2065956A1 DE2065956A1 (en) | 1977-07-14 |
| DE2065956B2 true DE2065956B2 (en) | 1980-06-04 |
| DE2065956C3 DE2065956C3 (en) | 1981-02-19 |
Family
ID=27173033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702065956 Expired DE2065956C3 (en) | 1969-01-31 | 1970-01-27 | p-Acyloxime-phenoxyacetic acids and derivatives, processes for their preparation and pharmaceutical agents |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2065956C3 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT389105B (en) * | 1988-02-23 | 1989-10-25 | Gerot Pharmazeutika | NEW AROMATIC ALDEHYDE, THEIR PRODUCTION AND USE |
| WO2008035359A2 (en) * | 2006-06-12 | 2008-03-27 | Cadila Healthcare Limited | Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
-
1970
- 1970-01-27 DE DE19702065956 patent/DE2065956C3/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2065956A1 (en) | 1977-07-14 |
| DE2065956C3 (en) | 1981-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2230383C3 (en) | Phenoxyalkylcarboxylic acid derivatives and processes for making the same | |
| DE2250327C2 (en) | Phenoxyibutyric acid derivatives, their acid addition salts, processes for their preparation and pharmaceutical agents | |
| DE2065956C3 (en) | p-Acyloxime-phenoxyacetic acids and derivatives, processes for their preparation and pharmaceutical agents | |
| DE1300955B (en) | p-Chlorophenoxyacetic acid (beta-dimethylaminoaethyl) ester, its hydrochloride and process for their preparation | |
| DE2137538C3 (en) | oxyamin and its salts, as well as a process for its production and medicinal products containing it | |
| DD150060A5 (en) | PROCESS FOR THE PREPARATION OF NEW PHENTHIAZINE DERIVATIVES | |
| DE3028776A1 (en) | Hypolipaemic 1,3-di:phenoxy-propanone derivs. - prepd. by oxidn. of hydroxy-propoxy cpds. with di:methyl sulphoxide | |
| DE1768553B1 (en) | [3- (N-Alkyl-acylamino) -2,4,6-triiodo-phenoxy] -alkoxy-alkanoic acids and X-ray contrast media containing them | |
| DE930329C (en) | Process for the preparation of alkyl or alkoxalkylaminobenzoic acid esters | |
| DE2029185A1 (en) | 2-azaquinolizidine derivs and salts neurotropic and anti - -histamine agents synthesis | |
| CH500941A (en) | Phenylethylamine derivs | |
| DE1802656B2 (en) | 3,3-Diphenylpropylaminoalkanol esters, processes for their preparation and pharmaceuticals containing these compounds | |
| EP0024616B1 (en) | 1-(3'-acyloxyphenyl)-2-aminoethanols, their acid addition salts, pharmaceutical compositions containing them and process for their preparation | |
| DE1768505B2 (en) | Phenethylamine compounds and processes for their production | |
| DE2429755A1 (en) | NITROIMIDAZOLE DERIVATIVES, THEIR SALT, PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS | |
| DE1795270C3 (en) | 1-hydroxy-2-pyridone | |
| AT228211B (en) | Process for the production of new phenothiazine derivatives, as well as acid addition salts and quaternary salts of these phenothiazine derivatives | |
| AT251565B (en) | Process for the production of new carboxylic acids | |
| CH645373A5 (en) | 2-HYDROXY-5- (1-HYDROXY-2- (4- (2-OXO-1-BENZIMIDAZOLINYL) -PIPERIDINO) ETHYL) BENZOESIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. | |
| DE2014199C3 (en) | 8-Substituted IO-piperazino-10, 11-dihydrodibenzo square bracket to b, square bracket to thiepine, their salts, process for the preparation of the same and pharmaceutical agents | |
| DE2500692C3 (en) | Derivatives of 4-amidoalkylene-4'oxy diphenyls | |
| AT221513B (en) | Process for the production of new basic esters and their salts | |
| DE1568361A1 (en) | New cyclobutene derivative and process for its preparation | |
| DE1493828C (en) | Benzamides and process for their preparation | |
| DE1062703B (en) | Process for the production of scopolin, its esters and ethers as well as their quaternary ammonium compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OGA | New person/name/address of the applicant | ||
| C3 | Grant after two publication steps (3rd publication) |